Prof Judith Breuer

Photo

Personal Profile

Name: Judith Breuer Email: j.breuer@ucl.ac.uk
Title: Prof Tel: 020 3108 2130
Department: Div of Infection & Immunity Fax: 020 3108 2119
Position: Professor of Virology (Honorary Consultant) Address: Divison of Infection & Immunity, Cruciform Building, London, WC1E 6BT
Research Domain: Global Health Web Page:  

Profile

Research Description

Professor Breuer's research at the MCR-UCL Centre for Molecular Virology has resulted in the successful development of methodoligies to recover low copy viral DNA from clinical samples and subsequent generation of template suitable for whole genome sequencing, including the detection of rare variants. She is currently applying these methods to investigate the genetic association of Varicella zoster (VZV) and Herpes Simplex Virus (HSV) with different disease states. Other research interests include genetic variation of alpha HSV and pathogenesis in skin tissue, and broader molecular diagnostic tools in viral disease. Professor Breuer also holds positions as Consultant Virologist at Great Ormond Street Hospital, and Head of the VZV Reference Laboratory (http://www.clinical-virology.org/pages/vzrl/vzrl_summary.html).

Research Activities

Viral Sequencing and Molecular Diagnosis

Education Description

UCL Collaborators

External Collaborators

Publications

    2014

    • Brown JR, Morfopoulou S, Hubb J, Emmett WA, Ip W, Shah D, Brooks T, Paine SML, Anderson G, Virasami A, Tong CYW, Clark DA, Plagnol V, Jacques TS, Qasim W, Hubank M, Breuer J (2014). Astrovirus VA1/HMO-C: an increasingly recognised neurotropic pathogen in immunocompromised patients. Clinical Infectious Diseases, , - .
    • Breuer J, Pacou M, Gautier A, Brown MM (2014). Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK.. Neurology, 83(2), e27 - e33. doi:10.1212/WNL.0000000000000584
    • Quinlivan M, Breuer J (2014). Clinical and molecular aspects of the live attenuated Oka varicella vaccine. REVIEWS IN MEDICAL VIROLOGY, 24(4), 254 - 273. doi:10.1002/rmv.1789
    • Jones M, Dry IR, Frampton D, Singh M, Kanda RK, Yee MB, Kellam P, Hollinshead M, Kinchington PR, O'Toole EA, Breuer J (2014). RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation. PLoS Pathogens, 10(1), - . doi:10.1371/journal.ppat.1003896
    • Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM (2014). Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea.. PLoS Med, 11(2), e1001598 - . doi:10.1371/journal.pmed.1001598
    • Hiwarkar P, Gajdosova E, Qasim W, Worth A, Breuer J, Chiesa R, Ridout D, Edelsten C, Moore A, Amrolia P, Veys P, Rao K (2014). Frequent occurrence of Cytomegalovirus retinitis during immune-reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.. Clin Infect Dis, , - . doi:10.1093/cid/ciu201
    • Breuer J, Pacou M, Gauthier A, Brown MM (2014). Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK.. Neurology, , - . doi:10.1212/WNL.0000000000000038

    2013

    • Papaevangelou V, Quinlivan M, Lockwood J, Papaloukas O, Sideri G, Critselis E, Papassotiriou I, Papadatos J, Breuer J (2013). Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. CLINICAL MICROBIOLOGY AND INFECTION, 19(5), E245 - E251. doi:10.1111/1469-0691.12131
    • Depledge D, Kundu S, Jensen N, Gray E, Jones M, Steinberg S, Gershon A, Kinchington P, Schmid D, Balloux F, Nichols R, Breuer J (2013). Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.. Mol Biol Evol, , - . doi:10.1093/molbev/mst210
    • Vukmanovic-Stejic M, Sandhu D, Sobande TO, Agius E, Lacy KE, Riddell N, Montez S, Dintwe OB, Scriba TJ, Breuer J, Nikolich-Zugich J, Ogg G, Rustin MH, Akbar AN (2013). Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans.. J Immunol, 190(3), 977 - 986. doi:10.4049/jimmunol.1201331
    • Watson SJ, Welkers MR, Depledge DP, Coulter E, Breuer JM, de Jong MD, Kellam P (2013). Viral population analysis and minority-variant detection using short read next-generation sequencing.. Philos Trans R Soc Lond B Biol Sci, 368(1614), 20120205 - . doi:10.1098/rstb.2012.0205
    • Antonsson A, Waterboer T, Bouwes Bavinck JN, Abeni D, de Koning M, Euvrard S, Feltkamp MC, Green AC, Harwood CA, Naldi L, Nindl I, Pfister HJ, Proby CM, Quint WG, Stockfleth E, Weissenborn SJ, Pawlita M, Neale RE, EPI-HPV-UV-CA group (2013). Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients.. Virology, 436(1), 91 - 99. doi:10.1016/j.virol.2012.10.037
    • Ebert K, Depledge DP, Breuer J, Harman L, Elliott G (2013). Mode of Virus Rescue Determines the Acquisition of VHS Mutations in VP22 Negative Viruses of Herpes Simplex Virus Type 1.. J Virol, , - . doi:10.1128/JVI.01654-13
    • Quinlivan M, Sengupta N, Papaevangelou V, Sauerbrei A, Grillner L, Rousseva R, Hague R, Lutsar I, Jogi P, Leca A, Grytchol R, Alain S, Breuer J (2013). Use of Oral Fluid to Examine the Molecular Epidemiology of Varicella Zoster Virus in the United Kingdom and Continental Europe. Journal of Infectious Diseases, 207(4), 588 - 593. doi:10.1093/infdis/jis649
    • Kundu S, Lockwood J, Depledge DP, Chaudhry Y, Aston A, Rao K, Hartley JC, Goodfellow I, Breuer J (2013). Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.. Clin Infect Dis, 57(3), 407 - 414. doi:10.1093/cid/cit287
    • Kennedy PGE, Montague P, Scott F, Grinfeld E, Ashrafi GH, Breuer J, Rowan EG (2013). Varicella-Zoster Viruses Associated with Post-Herpetic Neuralgia Induce Sodium Current Density Increases in the ND7-23 Nav-1.8 Neuroblastoma Cell Line. PLoS ONE, 8(1), e51570 - e51570. doi:10.1371/journal.pone.0051570

    2012

    • Conti VS, Breuer J, Smith C, Vigneswaran J, Shroff R (2012). CAN STRATIFICATION OF RISK FACTORS FOR MONONUCLEOSIS PREDICT POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS?. PEDIATRIC NEPHROLOGY, 27(9), 1815 - 1816.
    • Kennedy PG, Montague P, Breuer J, Grinfeld E, Ashrafi GH, Scott F, Rowan EG (2012). Varicella-Zoster virus isolates obtained from patients with zoster complicated by post-herpetic neuralgia induce significant increases in sodium current density in the ND7/23-Nav1.8 neuronal cell line. JOURNAL OF NEUROVIROLOGY, 18, 54 - 54.
    • Maple PAC, Breuer J, Quinlivan M, Kafatos G, Brown KE (2012). Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers. Journal of Clinical Virology, 53(3), 201 - 207.
    • Weissenborn S, Neale RE, Waterboer T, Abeni D, Bavinck JN, Green AC, Harwood CA, Euvrard S, Feltkamp MC, de Koning MN, Naldi L, Quint WG, Tessari G, Proby CM, Wieland U, Pfister H, EPI-HPV-UV-CA group (2012). Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients.. Med Microbiol Immunol, 201(2), 117 - 125. doi:10.1007/s00430-011-0212-3
    • Bate J, Chisholm J, Skinner R, Breuer J, Ramsay M, Wheatley K, Hambleton S, Heath PT (2012). Varicella post-exposure prophylaxis in children with cancer: urgent need for a randomised controlled trial. ARCHIVES OF DISEASE IN CHILDHOOD, 97(9), 853 - 854. doi:10.1136/archdischild-2012-302591
    • Sampogna F, Bavinck JN, Pawlita M, Abeni D, Harwood CA, Proby CM, Feltkamp MC, Euvrard S, Naldi L, Neale RE, Nindl I, Pfister H, Quint WG, Waterboer T, EPI-HPV-UV-CA Group (2012). Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients.. J Gen Virol, 93(Pt 1), 165 - 174. doi:10.1099/vir.0.035493-0
    • Singh M, Caley M, Jones M, Breuer J, O'Toole E (2012). Keratin 15 and VZV replication in skin.

    2011

    • Bibby DF, Clark DA, Mcelarney I, Breuer J (2011). Comparative evaluation of the seegene seeplex RV15 and real-time PCR for respiratory virus detection. Journal of Medical Virology, 83(8), 1469 - 1475. doi:10.1002/jmv.22125
    • Depledge DP, Palser AL, Watson SJ, Lai IY, Gray ER, Grant P, Kanda RK, Leproust E, Kellam P, Breuer J (2011). Specific capture and whole-genome sequencing of viruses from clinical samples.. PLoS One, 6(11), e27805 - . doi:10.1371/journal.pone.0027805
    • Gray ER, Garson JA, Breuer J, Edwards S, Kellam P, Pillay D, Towers GJ (2011). No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort.. PLoS One, 6(3), e18096 - . doi:10.1371/journal.pone.0018096
    • Quinlivan ML, Ayres KL, Kelly PJ, Parker SP, Scott FT, Johnson RW, Maple C, Breuer J (2011). Persistence of varicella-zoster virus viraemia in patients with herpes zoster.. J Clin Virol, 50(2), 130 - 135. doi:10.1016/j.jcv.2010.10.014
    • Quinlivan M, Breuer J, Schmidt DS (2011). Molecular studies of the Oka varicella vaccine. EXPERT REVIEW OF VACCINES, 10(9), 1321 - 1336. doi:10.1586/ERV.11.93
    • Manson AL, Gurugama P, Colston J, Gurdasani D, Sandhu MS, Breuer J, Seneviratne SL (2011). Familial recurrent herpes-simplex type 1 infection: an approach to characterise the molecular basis.
    • McDonald SL, Maple PA, Andrews N, Brown KE, Ayres KL, Scott FT, Al Bassam M, Gershon AA, Steinberg SP, Breuer J (2011). Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers.. J Virol Methods, 172(1-2), 60 - 65. doi:10.1016/j.jviromet.2010.12.021
    • Bate J, Chisholm J, Heath PT, Breuer J, Skinner R, Manley S, Patel S, Wheatley K, Ramsay M, Kearns PR, Hambleton S (2011). PEPtalk: postexposure prophylaxis against varicella in children with cancer. ARCH DIS CHILD, 96(9), 841 - 845. doi:10.1136/adc.2010.209650
    • Nichols RA, Averbeck KT, Poulsen AG, Breuer J, al Bassam MM, Cabral F, Aaby P (2011). Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics, 3(1), 12 - 18. doi:10.1016/j.epidem.2010.11.003
    • Proby CM, Harwood CA, Neale RE, Green AC, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, Schegget JT, Bouwes Bavinck JN, EPI-HPV-UV-CA group (2011). A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients.. Am J Transplant, 11(7), 1498 - 1508. doi:10.1111/j.1600-6143.2011.03589.x
    • Kanda RK, Quinlivan ML, Gershon AA, Nichols RA, Breuer J (2011). Population diversity in batches of the varicella Oka vaccine.. Vaccine, 29(17), 3293 - 3298. doi:10.1016/j.vaccine.2011.02.021
    • Khanom AB, Velvin C, Hawrami K, Schutten M, Patel M, Holmes MV, Atkinson C, Breuer J, Fitzsimons J, Geretti AM (2011). Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care.. J Infect, 62(1), 52 - 58. doi:10.1016/j.jinf.2010.11.002
    • Theodoridou K, Papaevangelou V, Papadogeorgaki E, Quinlivan M, Theodoridou M, Kakourou T, Breuer J (2011). ACTINIC VARICELLA VACCINE RASH. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 30(12), 1116 - 1118. doi:10.1097/INF.0b013e31822a841e

    2010

    • Goulleret N, Mauvisseau E, Essevaz-Roulet M, Quinlivan M, Breuer J (2010). Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).. Vaccine, 28(36), 5878 - 5882. doi:10.1016/j.vaccine.2010.06.056
    • Breuer J, Grose C, Norberg P, Tipples G, Schmid DS (2010). A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.. J Gen Virol, 91(Pt 4), 821 - 828. doi:10.1099/vir.0.017814-0
    • Masters N, Niphuis H, Verschoor E, Breuer J, Quinlivan M, Wawrzynczyk T, Stidworthy M (2010). DEBILITATING CLINICAL DISEASE IN A WILD-BORN CAPTIVE WESTERN LOWLAND GORILLA (GORILLA GORILLA GORILLA) CO-INFECTED WITH VARICELLA ZOSTER VIRUS (VZV) AND SIMIAN T-LYMPHOTROPIC VIRUS (STLV). J ZOO WILDLIFE MED, 41(4), 713 - 716.
    • Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC, EPI-HPV-UV-CA group (2010). Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma.. Cancer Res, 70(23), 9777 - 9786. doi:10.1158/0008-5472.CAN-10-0352
    • Gilleece Y, Chadwick DR, Breuer J, Hawkins D, Smit E, McCrae LX, Pillay D, Smith N, Anderson J, BHIVA Guidelines Subcommittee (2010). British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.. HIV Med, 11(10), 611 - 619. doi:10.1111/j.1468-1293.2010.00889.x
    • Gilleece Y, Chadwick DR, Breuer J, Hawkins D, Smit E, McCrae LX, Pillay D, Smith N, Anderson J, BHIVA Guidelines Subcomm (2010). British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010. HIV MED, 11(10), 611 - 619. doi:10.1111/j.1468-1293.2010.00889.x
    • Ashrafi GH, Grinfeld E, Montague P, Forster T, Ross A, Ghazal P, Scott F, Breuer J, Goodwin R, Kennedy PG (2010). Assessment of transcriptomal analysis of Varicella-Zoster-virus gene expression in patients with and without post-herpetic neuralgia.. Virus Genes, 41(2), 192 - 201. doi:10.1007/s11262-010-0515-2
    • Ayres KL, Talukder Y, Breuer J (2010). Humoral immunity following chickenpox is influenced by geography and ethnicity. J INFECTION, 61(3), 244 - 251. doi:10.1016/j.jinf.2010.06.012
    • Groves KC, Averbeck K, Quinlivan ML, Scott FT, Breuer J (2010). A case of nosocominal VZV transmission.. J Clin Virol, 48(3), 226 - 227. doi:10.1016/j.jcv.2010.03.003
    • Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD (2010). Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.. J Clin Virol, 48 Suppl 1, S2 - S7. doi:10.1016/S1386-6532(10)70002-0
    • Chouliaras G, Spoulou V, Quinlivan M, Breuer J, Theodoridou M (2010). Vaccine-Associated Herpes Zoster Opthalmicus and Encephalitis in an Immunocompetent Child. PEDIATRICS, 125(4), E969 - E972. doi:10.1542/peds.2009-2633
    • Breuer J (2010). VZV molecular epidemiology.. Curr Top Microbiol Immunol, 342, 15 - 42. doi:10.1007/82_2010_9
    • Agius E, Vukmanovic-Stejic M, Lacy KE, Sobande T, Breuer J, Ogg GS, Rustin MH, Akbar AN (2010). A defect of varicella-zoster-specific CD4+T-cell Infiltration after cutaneous antigen challenge in ageing.
    • Singh M, Breuer J, Heseltine R, Cerio R, Millar J, Philpott MP, O'Toole EA (2010). Varicella-zoster replication and its association with keratin 15 expression and Wnt signalling.
    • Groom HCT, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, Stoye JP, Bishop KN (2010). Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. RETROVIROLOGY, 7, - . doi:10.1186/1742-4690-7-10
    • Mallitt KA, O'Rourke P, Bouwes Bavinck JN, Abeni D, de Koning MN, Feltkamp MC, Green AC, Quint WG, Michael KM, Pawlita M, Pfister H, Weissenborn S, Waterboer T, Neale RE, EPI-HPV-UV-CA Group (2010). An analysis of clustering of betapapillomavirus antibodies.. J Gen Virol, 91(Pt 8), 2062 - 2067. doi:10.1099/vir.0.017970-0

    2009

    • Jones L, Malavige G, Jeffery K, Kempe E, Breuer J, Klenerman P, Ogg GS (2009). Tracking epitope-specific antiviral CD4(+) T cell responses to a live attenuated vaccine reveals ongoing functional responses. VACCINE, 27(52), 7398 - 7401. doi:10.1016/j.vaccine.2009.08.081
    • Weissenborn SJ, Neale R, de Koning MN, Waterboer T, Abeni D, Bouwes Bavinck JN, Wieland U, Pfister HJ, EPI-HPV-UV-CA Group (2009). Prevalence and multiplicity of cutaneous beta papilloma viruses in plucked hairs depend on cellular DNA input.. J Virol Methods, 161(2), 280 - 283. doi:10.1016/j.jviromet.2009.06.024
    • Waterboer T, Neale R, Michael KM, Sehr P, de Koning MN, Weissenborn SJ, Sampogna F, Abeni D, Green AC, Bouwes Bavinck JN, Pawlita M, EPI-HPV-UV-CA Group (2009). Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.. J Gen Virol, 90(Pt 8), 1986 - 1998. doi:10.1099/vir.0.010637-0
    • Singh M, Heseltine R, Millar J, Cerio R, Breuer J, O'Toole EA (2009). Localization of varicella-zoster virus reactivation in neuronal and adnexal structures in skin.
    • Ashrafi H, Grinfeld E, Forster T, Ross A, Ghazal P, Breuer J, Goodwin R, Kennedy PGE (2009). Transcriptomal analysis of Varicella-Zoster-Virus gene expression in patients with and without Post-Herpetic Neuralgia.
    • Pinquier D, Gagneur A, Balu L, Brissaud O, Gras Le Guen C, Hau-Rainsard I, Mory O, Picherot G, De Pontual L, Stephan JL, Maple P, Breuer J, Aubert M, Caulin E, Sana C, Pradat P, Soubeyrand B, Reinert P (2009). Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age.. Clin Vaccine Immunol, 16(4), 484 - 487. doi:10.1128/CVI.00397-08
    • Singh M, Breuer J, Heseltine R, Millar J, Philpott MP, O'Toole EA (2009). Varicella-zoster virus infection in skin shows prominent involvement of adnexal stem cell compartments.
    • Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, Weil-Olivier C, Wutzler P (2009). Varicella vaccination in Europe - taking the practical approach.. BMC Med, 7, 26 - . doi:10.1186/1741-7015-7-26
    • Quinlivan M, Sengupta N, Breuer J (2009). A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus.. J Clin Virol, 44(1), 66 - 69. doi:10.1016/j.jcv.2008.09.004
    • de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, Green AC, Harwood CA, Naldi L, Neale R, Nindl I, Proby CM, Quint WG, Sampogna F, ter Schegget J, Struijk L, Wieland U, Pfister HJ, Feltkamp MC, EPI-HPV-UV-CA group (2009). Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma.. J Gen Virol, 90(Pt 7), 1611 - 1621. doi:10.1099/vir.0.010017-0

    2008

    • Singh M, Breuer J, Cerio R, Millar J, Philpott MP, O'Toole EA (2008). Varicella zoster virus colocalizes within adnexal stem cell compartments of skin.
    • Singh M, Breuer J, Cerio R, Millar J, Philpott MP, O'Toole EA (2008). Immunohistochemical study of varicella-zoster virus infection in skin confirms prominent involvement of the follicular epithelium.
    • Tunbridge AJ, Breuer J, Jeffery KJ, British Infection Society (2008). Chickenpox in adults - clinical management.. J Infect, 57(2), 95 - 102. doi:10.1016/j.jinf.2008.03.004
    • Cronin JG, Mesher D, Purdie K, Evans H, Breuer J, Harwood CA, McGregor JM, Proby CM (2008). Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair.. Br J Dermatol, 159(1), 113 - 119. doi:10.1111/j.1365-2133.2008.08627.x
    • Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Seward J, Jumaan A, Finn A, Olcén P, Thiry N, Weil-Olivier C, Breuer J (2008). Varicella vaccination in Europe: are we ready for a universal childhood programme?. Eur J Pediatr, 167(1), 47 - 55. doi:10.1007/s00431-007-0424-0
    • Breuer J, Schmid DS, Gershon AA (2008). Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.. J Infect Dis, 197 Suppl 2, S147 - S151. doi:10.1086/529448
    • Breuer J, Schmid DS (2008). Vaccine Oka variants and sequence variability in vaccine-related skin lesions.. J Infect Dis, 197 Suppl 2, S54 - S57. doi:10.1086/522140
    • Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, Levin MJ, Macintyre CR (2008). The prevention and management of herpes zoster.. Med J Aust, 188(3), 171 - 176.
    • Breuer J (2008). Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission.. J Infect Dis, 197(5), 635 - 637. doi:10.1086/527421

    2007

    • Bouwes Bavinck JN, Euvrard S, Naldi L, Nindl I, Proby CM, Neale R, Abeni D, Tessari GP, Feltkamp MC, Claudy A, Stockfleth E, Harwood CA, EPI-HPV-UV-CA group (2007). Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy.. J Invest Dermatol, 127(7), 1647 - 1656. doi:10.1038/sj.jid.5700776
    • Hasnie FS, Breuer J, Parker S, Wallace V, Blackbeard J, Lever I, Kinchington PR, Dickenson AH, Pheby T, Rice AS (2007). Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.. Neuroscience, 144(4), 1495 - 1508.
    • Quinlivan ML, Ayres K, Ran H, McElwaine S, Leedham-Green M, Scott FT, Johnson RW, Breuer J (2007). Effect of viral load on the outcome of herpes zoster.. J Clin Microbiol, 45(12), 3909 - 3914. doi:10.1128/JCM.00874-07
    • Talukder YS, Kafatos G, Pinot de Moira A, Aquilina J, Parker SP, Crowcroft NS, Brown DW, Breuer J (2007). The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK.. Epidemiol Infect, 135(8), 1344 - 1353. doi:10.1017/S0950268807008497
    • Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ (2007). Recommendations for the management of herpes zoster.. Clin Infect Dis, 44 Suppl 1, S1 - 26. doi:10.1086/510206
    • Breuer J, Quinlivan M, Al Bassam M, Macdonald S, Nichols RA, Steinberg SP, Russa PL, Gershon AA (2007). DNA sequence variability in Oka vaccine isolates.. J Infect Dis, 196(5), 801 - 802. doi:10.1086/520520
    • Breuer J, Whitley R (2007). Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.. Herpes, 14 Suppl 2, 25 - 29.
    • Quinlivan ML, Gershon AA, Al Bassam MM, Steinberg SP, LaRussa P, Nichols RA, Breuer J (2007). Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.. Proc Natl Acad Sci U S A, 104(1), 208 - 212. doi:10.1073/pnas.0605688104
    • Sengupta N, Taha Y, Scott FT, Leedham-Green ME, Quinlivan M, Breuer J (2007). Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster.. J Infect Dis, 196(7), 1014 - 1020. doi:10.1086/521365

    2006

    • Essevaz-Roulet M, Guenaneche F, Delattre D, Watson M, Breuer J (2006). European varicella zoster virus identification program: Presentation of 2,5 year results from September 2003 until June 2006..
    • Parker SP, Quinlivan M, Taha Y, Breuer J (2006). Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR.. J Clin Microbiol, 44(11), 3911 - 3914. doi:10.1128/JCM.00346-06
    • Quinlivan ML, Gershon AA, Albassam MM, Steinberg SP, IaRussa P, Sharrar RA, Nichols RA, Breuer J (2006). Natural selection of rash-forming genotypes of the varicella vaccine virus within humans.
    • Quinlivan M, Breuer J (2006). Molecular studies of Varicella zoster virus.. Rev Med Virol, 16(4), 225 - 250. doi:10.1002/rmv.502
    • Maple PA, Gray J, Breuer J, Kafatos G, Parker S, Brown D (2006). Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.. Clin Vaccine Immunol, 13(2), 214 - 218. doi:10.1128/CVI.13.2.214-218.2006
    • Quinlivan MA, Gershon AA, Nichols RA, La Russa P, Steinberg SP, Breuer J (2006). Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.. J Infect Dis, 193(7), 927 - 930. doi:10.1086/500835
    • Pinot de Moira A, Edmunds WJ, Breuer J (2006). The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles.. Vaccine, 24(9), 1298 - 1307. doi:10.1016/j.vaccine.2005.09.028
    • Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J (2006). The burden of Herpes Zoster: a prospective population based study.. Vaccine, 24(9), 1308 - 1314. doi:10.1016/j.vaccine.2005.09.026
    • Molyneaux PJ, Parker S, Khan IH, Millar CG, Breuer J (2006). Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit.. J Clin Virol, 36(1), 76 - 78. doi:10.1016/j.jcv.2005.12.012

    2005

    • Breuer J (2005). Commentary on varicella vaccination of children in the United States: Assessment after the first decade 1995-2005. J CLIN VIROL, 33(2), 96 - 98. doi:10.1016/j.jcv.2005.03.003
    • Shahid M, Leedham-Green M, Breuer J (2005). Does the adherence of universal precautions correlate with the prevalence of blood borne infections?.
    • Breuer J (2005). Varicella vaccination for healthcare workers.. BMJ, 330(7489), 433 - 434. doi:10.1136/bmj.330.7489.433
    • Tang JW, Eames I, Li Y, Taha YA, Wilson P, Bellingan G, Ward KN, Breuer J (2005). Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. J HOSP INFECT, 61(4), 283 - 286. doi:10.1016/j.jhin.2005.05.017
    • Talukder Y, Gopal R, Andrews N, Glenn M, Breuer J, Brown D (2005). Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.. J Virol Methods, 128(1-2), 162 - 167. doi:10.1016/j.jviromet.2005.04.013
    • Quinlivan M, Breuer J (2005). Molecular and therapeutic aspects of varicella-zoster virus infection.. Expert Rev Mol Med, 7(15), 1 - 24. doi:10.1017/S146239940500966X
    • Quinlivan M, Gershon AA, Steinberg SP, Breuer J (2005). An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.. J Med Virol, 75(1), 174 - 180. doi:10.1002/jmv.20253
    • Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U (2005). Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers.. J Invest Dermatol, 125(1), 93 - 97. doi:10.1111/j.0022-202X.2005.23733.x
    • Purdie KJ, Surentheran T, Sterling JC, Bell L, McGregor JM, Proby CM, Harwood CA, Breuer J (2005). Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals.. J Invest Dermatol, 125(1), 98 - 107. doi:10.1111/j.0022-202X.2005.23635.x
    • Purdie K, Surentheran T, Sterling J, Bell L, McGregor J, Proby C, Harwood C, Leigh I, Breuer J (2005). Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals.
    • Breuer J (2005). Varicella vaccination for healthcare workers - Is beneficial to patients and staff. BRIT MED J, 330(7489), 433 - 434.
    • Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, Oliver RT, Baithun S (2005). Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis.. J Clin Pathol, 58(2), 207 - 210. doi:10.1136/jcp.2004.017152
    • Shahid M, Leedham-Green M, Breuer J (2005). Does adherence to universal precautions correlate with the prevalence of blood-borne infections?. J Hosp Infect, 60(3), 289 - 290. doi:10.1016/j.jhin.2004.12.006

    2004

    • Breuer J (2004). Varicella immunisation for staff and inmates of institutions: is this the next step in the UK?. Commun Dis Public Health, 7(3), 162 - 163.
    • Quinlivan ML, Gershon AA, Steinberg SP, Breuer J (2004). Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.. J Infect Dis, 190(4), 793 - 796. doi:10.1086/423210
    • Taha YA, Quinlivan M, Scott FT, Leedham-Green M, Hawrami K, Thomas JM, Breuer J (2004). Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains?. J Med Virol, 73(4), 631 - 635. doi:10.1002/jmv.20137
    • Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, Wojnarowska F, Breuer J, McGregor JM (2004). Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.. Br J Dermatol, 150(5), 949 - 957. doi:10.1111/j.1365-2133.2004.05847.x
    • Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, Wojnarowska F, Breuer J, Mcgregor JM (2004). Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. BRIT J DERMATOL, 150(5), 949 - 957. doi:10.1111/j.0007-0963.2004.05847.x
    • Kennedy PG, Grinfeld E, Craigon M, Vierlinger K, Roy D, Breuer J, Ghazal P (2004). Use of a Varicella-Zoster virus (VZV) microarray to identify global alterations in viral gene transcription in different cell types and different clinical VZV isolates. J NEUROVIROL, 10, 113 - 114.
    • Breuer J (2004). Microarray analysis: the evolving story of oral polio vaccines.. Heredity (Edinb), 92(1), 3 - 4. doi:10.1038/sj.hdy.6800373

    2003

    • Breuer J (2003). Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK?. J Med Microbiol, 52(Pt 1), 1 - 3.
    • Barrett-Muir W, Scott FT, Aaby P, John J, Matondo P, Chaudhry QL, Siqueira M, Poulsen A, Yaminishi K, Breuer J (2003). Genetic variation of varicella-zoster virus: evidence for geographical separation of strains.. J Med Virol, 70 Suppl 1, S42 - S47. doi:10.1002/jmv.10319
    • Scott FT, Leedham-Green ME, Barrett-Muir WY, Hawrami K, Gallagher WJ, Johnson R, Breuer J (2003). A study of shingles and the development of postherpetic neuralgia in East London.. J Med Virol, 70 Suppl 1, S24 - S30. doi:10.1002/jmv.10316
    • Breuer J (2003). Commentary on Herpes zoster guidelines of the German Dermatological Society. J CLIN VIROL, 26(3), 291 - 293. doi:10.1016/S1386-6532(03)00032-5
    • Breuer J (2003). Monitoring virus strain variation following infection with VZV: is there a need and what are the implications of introducing the Oka vaccine?. Commun Dis Public Health, 6(1), 59 - 62.
    • Laundy M, Ajayi-Obe E, Hawrami K, Aitken C, Breuer J, Booy R (2003). Influenza A community-acquired pneumonia in East London infants and young children.. Pediatr Infect Dis J, 22(10 Suppl), S223 - S227. doi:10.1097/01.inf.0000092192.59459.8b
    • Wagenaar TR, Grose C, Loparev VN, Schmid DS, Breuer J (2003). Genomic analysis of varicella-zoster virus: primers for individual open reading frames.. J Clin Virol, 28(1), 104 - 110.

    2002

    • Breuer J (2002). Vaccination to prevent varicella and shingles - Author's reply. J CLIN PATHOL, 55(5), 399 - 399.
    • PILLAY D, Emery VC, MUTIMER D, Ogilvie MM, Carman W, Mutton K, Wreghitt T, Westmoreland D, Breuer J, Zuckerman M (2002). Guidelines for laboratory monitoring of treatment of persistent virus infections. Journal of Clinical Virology, 25(1), 73 - 92.
    • McGregor JM, Harwood CA, Brooks L, Fisher SA, Kelly DA, O'nions J, Young AR, Surentheran T, Breuer J, Millard TP, Lewis CM, Leigh IM, Storey A, Crook T (2002). Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer.. J Invest Dermatol, 119(1), 84 - 90. doi:10.1046/j.1523-1747.2002.01655.x
    • Muir WB, Nichols R, Breuer J (2002). Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination.. J Virol, 76(4), 1971 - 1979.
    • Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulsen A, Siqueira M, Takahashi M, Talukder Y, Yamanishi K, Leedham-Green M, Scott FT, Thomas SL, Breuer J (2002). The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation.. J Infect Dis, 186(7), 888 - 894. doi:10.1086/344228
    • Breuer J (2002). Studies on shingles, is the virus ordinary chickenpox virus?. Rev Med Virol, 12(1), 5 - 11.

    2001

    • Barrett-Muir W, Hawrami K, Clarke J, Breuer J (2001). Investigation of varicella-zoster virus variation by heteroduplex mobility assay.. Arch Virol Suppl, (17), 17 - 25.
    • Smith NA, Shaw T, Berry N, Vella C, Okorafor L, Taylor D, Ainsworth J, Choudhury A, Daniels RS, El-Gadi S, Fakoya A, Moyle G, Oxford J, Tedder R, O'Shea S, de Ruiter A, Breuer J (2001). Antiretroviral therapy for HIV-2 infected patients. J INFECTION, 42(2), 126 - 133. doi:10.1053/jinf.2001.0792
    • Breuer J, Scott F, Leedham-Green M (2001). Postherpetic neuralgia. Pathogenesis of postherpetic neuralgia should be determined.. BMJ, 322(7290), 860 - .
    • Breuer J (2001). Vaccination to prevent varicella and shingles.. J Clin Pathol, 54(10), 743 - 747.
    • Harwood CA, Crook T, Brooks L, Kelly DA, Young AR, Breuer J, Millard TP, Lewis CM, Leigh IM, Storey A, McGregor JM (2001). Association between p53 codon 72 polymorphism and susceptibility to skin cancer. J INVEST DERMATOL, 117(3), 777 - 777.
    • Wareham DW, Breuer J, Healy MT, Goldhill DR (2001). Pneumonitis in an elderly Bangladeshi man.. J Clin Pathol, 54(6), 494 - .

    2000

    • Helbert M, Breuer J (2000). Monitoring patients with HIV disease.. J Clin Pathol, 53(4), 266 - 272.
    • Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM (2000). Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.. J Med Virol, 61(3), 289 - 297.
    • Barrett-Muir W, Breuer J, Millar C, Thomas J, Jeffries D, Yaqoob M, Aitken C (2000). CMV viral load measurements in whole blood and plasma--which is best following renal transplantation?. Transplantation, 70(1), 116 - 119.
    • Ushiro-Lumb I, Norman J, Skinner C, Murphy M, Breuer J, Aitken C (2000). Does HIV-1 subtype influence genotypic changes associated with anti-retroviral failure. AIDS, 14, S121 - S121.
    • Ushiro-Lumb I, Norman J, Skinner C, Murphy M, Breuer J, Aitken C (2000). Performance of a HIV-1 genotyping assay with non-B subtypes: the East London experience. AIDS, 14, S120 - S120.
    • Wareham DW, Breuer J (2000). Management of occupational exposure to hepatitis C: survey of United Kingdom practice.. Commun Dis Public Health, 3(4), 295 - 296.
    • Whittam LR, MacDonald DM, Calonje E, Breuer J, Spink P, Barker JN (2000). Truncal hypopigmented macules and facial hyperpigmented papules.. Arch Dermatol, 136(2), 260 - 264.

    1999

    • Aitken C, Hawrami K, Miller C, Barrett Muir W, Yaqoob M, Breuer J (1999). Simultaneous treatment of cytomegalovirus and varicella zoster infections in a renal transplant recipient with ganciclovir: use of viral load to monitor response to treatment.. J Med Virol, 59(3), 412 - 414.
    • Vella C, King D, Zheng NN, Fickenscher H, Breuer J, Daniels RS (1999). Alterations in the V1/V2 domain of HIV-2CBL24 glycoprotein 105 correlate with an extended cell tropism.. AIDS Res Hum Retroviruses, 15(15), 1399 - 1402. doi:10.1089/088922299310106
    • Harwood CA, Spink PJ, Surentheran T, Leigh IM, de Villiers EM, McGregor JM, Proby CM, Breuer J (1999). Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts.. J Clin Microbiol, 37(11), 3545 - 3555.
    • Aitken C, Barrett-Muir W, Millar C, Templeton K, Thomas J, Sheridan F, Jeffries D, Yaqoob M, Breuer J (1999). Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation.. J Clin Microbiol, 37(9), 2804 - 2807.
    • Aitken C, Barrett-Muir W, Raftery M, Breuer J (1999). The clinical significance of ganciclovir resistance in a renal transplant patient.. Nephrol Dial Transplant, 14(4), 1050 - 1051.
    • Hawrami K, Breuer J (1999). Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus.. J Virol Methods, 79(1), 33 - 40.
    • Harwood CA, McGregor JM, Proby CM, Breuer J (1999). Human papillomavirus and the development of non-melanoma skin cancer.. J Clin Pathol, 52(4), 249 - 253.
    • Mulatero C, Surentheran T, Breuer J, Rudd RM (1999). Simian virus 40 and human pleural mesothelioma.. Thorax, 54(1), 60 - 61.
    • Johnson RW, Dworkin RH, Breuer J (1999). Untitled. EUR J PAIN, 3(4), 297 - 299.

    1998

    • Barrett-Muir WY, Aitken C, Templeton K, Raftery M, Kelsey SM, Breuer J (1998). Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patients.. J Clin Microbiol, 36(9), 2554 - 2556.
    • Grassly NC, Xiang Z, Ariyoshi K, Aaby P, Jensen H, Schim van der Loeff M, Dias F, Whittle H, Breuer J (1998). Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype.. J Virol, 72(10), 7895 - 7899.
    • Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998). p53 polymorphism and risk of cervical cancer - Reply. NATURE, 396(6711), 532 - 532.
    • Pawson R, Richardson DS, Pagliuca A, Kelsey SM, Hoque S, Breuer J, Newland AC, Mufti GJ (1998). Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases.. Leuk Lymphoma, 31(1-2), 177 - 185. doi:10.3109/10428199809057597
    • Oliver RT, Breuer J, Nouri AM, Campo S (1998). Malignancy associated papillomaviruses and morphology of human bladder cancer.. Cancer Surv, 31, 29 - 47.
    • Harwood CA, Spink PJ, Surentheran T, Leigh IM, Hawke JL, Proby CM, Breuer J, McGregor JM (1998). Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers.. J Invest Dermatol, 111(1), 123 - 127. doi:10.1046/j.1523-1747.1998.00240.x
    • Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.. Nature, 393(6682), 229 - 234. doi:10.1038/30400
    • Smith NA, Kennedy J, Bewley S, O'Shea S, du Mont G, Berry N, Breuer J, de Ruiter A (1998). HIV-2 in pregnancy: to treat or not to treat?. Int J STD AIDS, 9(4), 246 - .
    • Storey A, Harwood C, Matlashewski G, Thomas M, Breuer J, Leigh I, Gardiol D, Kalita A, Banks L (1998). A genetic polymorphism determines susceptibility to Human Papillomavirus associated cancers.. J INVEST DERMATOL, 110(4), 485 - 485.
    • Surentheran T, Harwood CA, Spink PJ, Sinclair AL, Leigh IM, Proby CM, McGregor JM, Breuer J (1998). Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach.. J Clin Pathol, 51(8), 606 - 610.

    1997

    • Xiang Z, Ariyoshi K, Wilkins A, Dias F, Whittle H, Breuer J (1997). HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau.. AIDS Res Hum Retroviruses, 13(6), 501 - 505.
    • Hawrami K, Hart IJ, Pereira F, Argent S, Bannister B, Bovill B, Carrington D, Ogilvie M, Rawstorne S, Tryhorn Y, Breuer J (1997). Molecular epidemiology of varicella-zoster virus in East London, England, between 1971 and 1995.. J Clin Microbiol, 35(11), 2807 - 2809.
    • Hawrami K, Breuer J (1997). Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain.. J Med Virol, 53(1), 60 - 62.

    1996

    • Hoque S, Kelsey S, van der Walt JD, Breuer J (1996). Experience of human lymphotropic virus type I (HTLV-I) in an East London hospital.. J Infect, 32(1), 33 - 39.
    • Jenks P, Raftery MJ, Breuer J (1996). HTLV-I screening in Britain. Donors and recipients of organ transplants should also be screened.. BMJ, 312(7032), 707 - .
    • Aitken C, Booth J, Booth M, Boriskin Y, Testard H, Kempley S, Breuer J (1996). Molecular epidemiology and significance of a cluster of cases of CMV infection occurring on a special care baby unit.. J Hosp Infect, 34(3), 183 - 189.
    • Aitken C, BarrettMuir W, Hill S, Jeffries D, Breuer J, Parkin J (1996). Does the measurement of cytomegalovirus (CMV) DNA concentrations using the digene hybrid capture assay predict response to therapy?. AIDS, 10, OP32 - OP32.
    • Harwood CA, Spink PJ, Breuer J, Proby CM, Leigh IM, Raftery MJ, Cunningham J (1996). Human papillomavirus (HPV) carriage in renal transplant recipients (RTRS) at high risk of developing non-melanoma skin cancers (NMSC).. J AM SOC NEPHROL, 7(9), A3428 - A3428.
    • Richardson DS, Pawson R, Kelsey SM, Pagliuca A, Hoque S, Breuer J, Mufti GJ, Newland AC (1996). Therapy at adult T-cell leukaemia/lymphoma: Experience of two London hospitals. BRIT J HAEMATOL, 93, 1169 - 1169.
    • Caldwell CJ, Barrett WY, Breuer J, Farmer SF, Swash M (1996). HTLV-1 polymyositis.. Neuromuscul Disord, 6(3), 151 - 154.
    • Hawrami K, Harper D, Breuer J (1996). Typing of varicella zoster virus by amplification of DNA polymorphisms.. J Virol Methods, 57(2), 169 - 174.
    • Pawson R, Richardson D, Pagliuca A, Kelsey S, Hoque S, Breuer J, Newland AC, Mufti GJ (1996). Adult T-cell leukaemia/lymphoma in London: Clinical experience of 21 cases.. BRIT J HAEMATOL, 93, 285 - 285.
    • Jenks PJ, Breuer J (1996). Acyclovir in chickenpox.. Arch Dis Child, 74(2), 184 - .

    1995

    • JOHNSON R, MANDAL B, BOWSHER D, BREUER J, COOK S, GRIFFITHS P, JEFFRIES D, MCKENDRICK M, MARSH R, MILLER E, PROCTOR S, STILLMAN P, WHITAKER M, WYNDHAM M (1995). GUIDELINES FOR THE MANAGEMENT OF SHINGLES - REPORT OF A WORKING GROUP OF THE BRITISH-SOCIETY-FOR-THE-STUDY-OF-INFECTION (BSSI). J INFECTION, 30(3), 193 - 200.
    • Jenks PJ, Barrett WY, Raftery MJ, Kelsey SM, van der Walt JD, Kon SP, Breuer J (1995). Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation.. Clin Infect Dis, 21(4), 992 - 993.

    1994

    • Lewis DA, Jenks P, Gent AE, Side L, Breuer J (1994). Varicella-zoster vaccination for health care workers. Lancet, 343(8909), 1362 - 1363.

    1990

    • Breuer J, Jeffries DJ (1990). Control of viral infections in hospitals.. J Hosp Infect, 16(3), 191 - 221.
    • MURPHY S, BREUER J, CHINN R, GOLDMEIER D, HARRIS JRW (1990). HIV ANTIBODY POSITIVE SUB-SAHARAN AFRICAN PATIENTS IN UK - REPLY. LANCET, 335(8680), 47 - 47.
    • Breuer J, Kenny C, Shah N, Kitchen VS, Harris JR, Parry JV, Jeffries DJ (1990). HIV-2 antibody in a low-risk individual.. Lancet, 336(8711), 384 - .

    1989

    • Breuer J, Jeffries DJ (1989). Rape and seroconversion.. BMJ, 299(6706), 1032 - .
    • Murphy S, Breuer J, Chinn R, Goldmeier D, Harris JR (1989). HIV infection among sub-Saharan African patients in the UK.. Lancet, 2(8673), 1225 - .
    • BREUER J, JEFFRIES DJ (1989). RAPE AND SUBSEQUENT SEROCONVERSION. BRIT MED J, 299(6706), 1032 - 1032.

    1988

    • Breuer J, Bragman SG, Sahatlevan MD, Philpott-Howard JN, Casewell MW (1988). The possible role of ciprofloxacin in the treatment of endocarditis caused by Pseudomonas aeruginosa.. J Infect, 16(1), 106 - 107.

    1987

    • Breuer J, Moniz C, Baldwin D, Parsons V (1987). The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.. Nephrol Dial Transplant, 2(5), 347 - 350.
    • Burnie JP, Matthews R, Lee W, Philpott-Howard J, Brown R, Damani N, Breuer J, Honeywell K, Jordans Z (1987). Four outbreaks of nosocomial systemic candidiasis.. Epidemiol Infect, 99(1), 201 - 211. doi:10.1017/S0950268800067030